Early type 1 diabetes detection and disease-modifying therapy: a new implementation challenge for primary care and endocrinology
Frontiers in Clinical Diabetes and Healthcare · 20.11.2026 · 7
DOI: 10.3389/fcdhc.2026.2014364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Clinical Diabetes and Healthcare, online erschienen am 20.11.2026. Verfasst von Jennifer Goldman und 3 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
The recognition that type 1 diabetes (T1D) progresses through identifiable presymptomatic stages before the onset of symptomatic disease, together with the availability of disease-modifying therapy, represents a fundamental shift in the management of T1D. This Perspective examines the emerging implementation challenges associated with early T1D detection and highlights the evolving roles of primary care clinicians and endocrinology/diabetology practices in identifying individuals at increased risk, implementing evidence-based screening and monitoring strategies, and integrating disease-modifying therapy into clinical practice. We discuss current recommendations for targeted screening, disease staging, patient education, longitudinal surveillance, multidisciplinary care, and practical considerations for incorporating early T1D detection into routine practice. As screening programs expand and therapeutic options continue to evolve, developing standardized clinical workflows will be essential to realizing the potential of early detection to improve patient outcomes and reduce the burden of symptomatic disease.
Zitieren
APA
Goldman, J., Bellini, N., Metcalf, E., & Busch, R. (2026). Early type 1 diabetes detection and disease-modifying therapy: a new implementation challenge for primary care and endocrinology. Frontiers in Clinical Diabetes and Healthcare, 7. https://doi.org/10.3389/fcdhc.2026.2014364
Vancouver
Goldman J, Bellini N, Metcalf E, Busch R. Early type 1 diabetes detection and disease-modifying therapy: a new implementation challenge for primary care and endocrinology. Frontiers in Clinical Diabetes and Healthcare. 2026;7. doi:10.3389/fcdhc.2026.2014364
BibTeX
@article{Goldman2026,
author = {Goldman, Jennifer and Bellini, Natalie and Metcalf, Eric and Busch, Robert},
title = {Early type 1 diabetes detection and disease-modifying therapy: a new implementation challenge for primary care and endocrinology},
journal = {Frontiers in Clinical Diabetes and Healthcare},
year = {2026},
volume = {7},
doi = {10.3389/fcdhc.2026.2014364}
}
EUVIMED